Malaria Diagnostics Market Overview
The Malaria Diagnostics Market is anticipated to reach USD 0.82 Billion by 2032 at 5.7% CAGR during the forecast period 2023-2032. Malaria is a parasitic disease conveyed by the bite of infected anopheles mosquitoes. The Plasmodium parasite is transmitted by infected mosquitos. The parasite is released into the circulation after being bitten by an infected mosquito. When the human body becomes the parasite's host, the parasite grows in the liver. The adult parasite enters the bloodstream and infects red blood cells after a few days. Fever, vomiting, weakness, and headache are common symptoms of malaria in humans. In recent years, the global market for malaria diagnostics has grown dramatically. The market's expansion is mostly due to developments in technological innovations in diagnostic instruments, as well as rising demand for treatment in malaria-endemic nations. Furthermore, factors such as increased collaboration between research institutes and industry, as well as government funding, are expected to support market expansion in the estimated timeframe. Factors such as a lack of solid import-export rules, lack of knowledge, a weak regulatory framework, and a lack of suitable monitoring standards at the country level, on the other hand, are expected to limit the market's growth in the next years.
Malaria Diagnostics Market Segmentation
The malaria diagnostics market has been segmented on the basis of technology and end-user.
On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR).
On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.
On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.
The European malaria diagnostics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The malaria diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The malaria diagnostics market in the Middle East and Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Malaria Diagnostics Share, by Region, 2017 (%)
Source: MRFR Analysis
In the malaria diagnostics market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. In 2016, global governments of malaria-endemic countries have invested USD 2.7 billion in malaria control and elimination efforts. The US was the largest contributor by providing USD 1 billion for the eradication of malaria.
The European market is expected to hold the least share due to the growing number of malaria-free countries in the region.
The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism. The Asia-Pacific remains to be the second largest burden of malaria globally with 22 malaria-endemic countries accounting for roughly 28 million cases and 45,000 deaths every year. The WHO figures say that in the Asia-Pacific region, Myanmar, Pakistan, India, and Indonesia carry the highest malaria burden accounting for 89% of all malaria cases in the region.
The market in the Middle East and Africa is expected to account for the smallest share of the global malaria diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities. Sub-Saharan Africa remains to bring an excessively high share of the global malaria burden on the Middle Eastern and African market. the region was home to 90% of malaria incidences and 92% of malaria deaths in 2015
Malaria Diagnostics Market Key Players
Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.Recent Development
In March 2022, Audere, a digital health
foundation dedicated to improving global health, announced a partnership with Medical Diagnostech, a designer and manufacturer of lateral flow fast diagnostic test kits. Medical Diagnostech's MD SARS-nCoV-2 Antigen Device1 will be paired with Audere's HealthPulsedigital companion app as part of the agreement. In February 2022, Kemri released the first domestically produced malaria and Covid-19 test kits. Both were freed by Health CAS Rashid Aman. Researchers of the Kenya Medical Research Institute created them. According to Aman, they have performed between three and four million Covid-19 tests thus far, and they are expensive. The ministry will assist the company with manufacturing and will be the product's primary consumer.
Global Malaria Diagnostics Market, by Technique
- Rapid diagnostic tests
- Molecular diagnostic tests
- Polymerase chain reaction (PCR)
- Real-time polymerase chain reaction (RT-PCR)
Global Malaria Diagnostics Market, by End-Users
- Community healthcare
Global Malaria Diagnostics Market, by Region
- North America
- South America
- Western Europe
- Rest of Western Europe
- Eastern Europe
- South Korea
- Rest of Asia-Pacific
Middle East & Africa
- Governmental Agency
- Educational Organizations
- Medical Device Manufacturers
- Research Institutes and Academic Centers
- Market Research and Consulting
Malaria Diagnostics Market Highlights:
Frequently Asked Questions (FAQ) :
lack of adequate medical facilities in emerging regions is the major restraint on the global Malaria Diagnostics Market.
Malaria Diagnostics Market is expected to exhibit a strong 5.7% CAGR over the forecast period from 2023 to 2032.
Growing awareness about malaria is the major driver for the market.
North America is anticipated to account for the largest share in the Global Malaria Diagnostics Market.
Leading players in the Malaria Diagnostics Market include Sysmex Partec, Access Bio, and Beckman Coulter, among others.
Key Questions Answered
Request Free Sample
- ✅Global Market Outlook
- ✅In-depth analysis of global and regional trends
- ✅Analyze and identify the major players in the market, their market share, key developments, etc.
- ✅To understand the capability of the major players based on products offered, financials, and strategies.
- ✅Identify disrupting products, companies, and trends.
- ✅To identify opportunities in the market.
- ✅Analyze the key challenges in the market.
- ✅Analyze the regional penetration of players, products, and services in the market.
- ✅Comparison of major players’ financial performance.
- ✅Evaluate strategies adopted by major players.
Why Choose Market Research Future?
Speak to Analyst
- ✅Vigorous research methodologies for specific market.
- ✅Knowledge partners across the globe
- ✅Large network of partner consultants.
- ✅Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- ✅Trusted by fortune 500 companies/startups/universities/organizations
- ✅Large database of 5000+ markets reports.
- ✅Effective and prompt pre- and post-sales support.